Prostaglandin D2, a potential antineoplastic agent.
D000818:Animals; D000970:Antineoplastic Agents; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004261:DNA Replication / Q000187:drug effects; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy*; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000503:physiopathology; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D015230:Prostaglandin D2; D011453:Prostaglandins / Q000494:pharmacology / Q000627:therapeutic use*; D011457:Prostaglandins D / Q000494:pharmacology / Q000627:therapeutic use*; D012334:RNA, Neoplasm / Q000096:biosynthesis
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D011453:Prostaglandins; D011457:Prostaglandins D; D012334:RNA, Neoplasm; D015230:Prostaglandin D2